Get to know and reach out to the experts at Profil.

Dr. Jorge Arrubla Scientific Study Advisor Jorge is part of our project development team. He is your contact partner, among others, for the following areas: Medications for Type 2 Diabetes Imaging methods Vascular methods

Short Bio

Jorge is a physician who did a PhD in biomedical and pharmaceutical sciences after graduating from medical school. He got both scientific and clinical experience before joining Profil in 2015, where he started a career in clinical research with a special interest in medications for type 2 diabetes. He obtained the board certification as clinical pharmacologist in 2020.

Publications

Here are Jorge's recent publications:

• Bergougnan L, Andersen G, Plum-Mörschel L, Evaristi MF, Poirier B, Tardat A, Ermer M, Herbrand T, Arrubla J, Coester HV, Sansone R, Heiss C, Vitse O, Hurbin F, Boiron R, Benain X, Radzik D, Janiak P, Muslin AJ, Hovsepian L, Kirkesseli S, Deutsch P, Parkar AA. Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial. Br J Clin Pharmacol 2020 Oct 30. doi: 10.1111/bcp.14632. Online ahead of print
• Heise T, Meiffren G, Alluis B, Seroussi C, Ranson A, Arrubla J, Correia J, Gaudier M, Soula O, Soula R, DeVries JH, Klein O, Bode B.
  BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
  DIABETES OBES METAB 2018 Dec 18. doi: 10.1111/dom. 13621. (Epub ahead of print)

Browse Jorge's entire list of publications or Profil's recent list of publications to see our other publications.

Selected Achievements and Work Experience